Neovacs SA retweetledi
NEW RESEARCH: LLDAS (#Lupus low disease activity state) attainment is associated with significant protection against flare and damage accrual in #SLE thelancet.com/journals/lanrh… #LancetRheumatology
English
Neovacs SA
140 posts
Neovacs SA
@Neovacs
#Neovacs is a French company focused on the development of #Kinoids #therapeutic #vaccines for the treatment of autoimmune and inflammatory diseases and #cancer
#Paris #Boston Katılım Aralık 2015
207 Takip Edilen877 Takipçiler
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study bit.ly/2lKdTa0
English
Good News for IFNalpha targeting approaches to halt lupus disease
Lupus Research@LupusResearch
The Lupus Research Alliance is excited to share the good news that a potential new medicine for lupus, anifrolumab, reduced disease activity versus placebo in a second Phase III study. Read more about this exciting study: bit.ly/Phase3Ani #lupusnews
English
Neovacs SA retweetledi
What is lupus? Watch as #MacktheMolecule breaks it down.
#whatislupus #lupus #lupusvideo #SLE #autoimmune #breakingthrough #preventlupus #treatlupus #curelupus
English
Neovacs SA retweetledi
It’s been quite a month! Filled with stories of hope from researchers, advocates and people with lupus. Thank you for all you do to help advance lupus research! With your continued support, we will continue keeping up the momentum all year long! #LupusAwarenessMonth
English
#Neovacs announces appointment of Dr. Virginia Pascual bit.ly/2IR6oau #lupus #clinicalresearch #NewsUpdate
English
English
Neovacs presented its Type 1 diabetes project using IFN-K vaccine @ADA_DiabetesPro scientific session
English
#neovacs to present the pre-clinical results of IFNalpha Kinoid to treat Type 1 Diabetes at #ADA2019 bit.ly/2ImG32t
English
Le Journal des Biotechs@: Interview Miguel Sieler, CEO de Neovacs bit.ly/2UY18EO
Français
Neovacs to attend the 13th International Congress on Systemic Lupus Erythematosus in San Francisco, California, April 5-8 2019
#LupusCongress #Lupus2019 #Lupus #Congress #SanFrancisco
English
Neovacs SA retweetledi
Miguel Sieler Directeur Général @Neovacs invité de @DidierTestot @LaBourseEtLaVie "Nous sommes dans le trio de tête des entreprises dans le développement clinique pour le lupus". #Biotech labourseetlavie.com/strategie-et-r…
Français
Neovacs’ Investigational Lupus Vaccine Shows Positive Results in Phase 2b Trial lupusnewstoday.com/2018/07/11/neo…
English
Get to Know 15 Awesome Biotechs in Paris labiotech.eu/15-awesome-bio…
English
Réécoutez l’ITW de Miguel Sieler, directeur général de #Neovacs - diffusée en direct sur BFMBusiness le 04/07 à 16h bfmbusiness.bfmtv.com/mediaplayer/vi… via @BFMBusiness
Français
French Lupus Vaccine Ready to Move Into Phase III labiotech.eu/neovacs-lupus-…
English
[VIDEO] Interview de Miguel SIELER, Directeur Général de Néovacs boursier.com/actions/actual… via @Boursier_com
Français
#Neovacs will hold a Webcast conference call today at 10:00 am CEST, log in via the following link: bit.ly/2NlTCRC
English
#Néovacs tiendra une conférence téléphonique aujourd'hui à 10h00.am CEST, suivez en direct la présentation via le lien suivant : bit.ly/2NlTCRC
Français